Effects of Mitophagy on Regulatory T Cell Function in Patients With Myasthenia Gravis

被引:15
|
作者
Wang, Na [1 ]
Yuan, Jiang [1 ]
Karim, Md Rezaul [1 ,2 ]
Zhong, Ping [3 ]
Sun, Yan-Peng [1 ]
Zhang, Hong-Yan [1 ]
Wang, Yun-Fu [1 ,2 ]
机构
[1] Hubei Univ Med, Dept Neurol, Taihe Hosp, Shiyan, Peoples R China
[2] Hubei Univ Med, Biomed Res Inst, Shiyan, Peoples R China
[3] Hubei Univ Med, Dept Prevent Med, Shiyan, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2020年 / 11卷
基金
中国国家自然科学基金;
关键词
myasthenia gravis; mitophagy; regulatory T cell; rapamycin; 3-methyladenine; IMMUNOSUPPRESSIVE THERAPY; AUTOPHAGY; MTOR; TREG; TACROLIMUS; SYSTEM; ROLES;
D O I
10.3389/fneur.2020.00238
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: This study was conducted to determine whether regulatory T cells (CD4(+)CD25(+)T, Tregs) show abnormal mitophagy as well as the function of Tregs in patients with myasthenia gravis (MG). Methods: CD4(+)T cells and CD4(+)CD25(+)Treg cells were obtained from 15 patients with MG (MG group) and 15 controls (N group). Tregs from the MG group were subjected to rapamycin-induced culture for 48 h (Rapa group) and 3-methyladenine-induced culture for 48 h (3-MA group). The levels of mitophagy in Tregs were then observed through electron and confocal microscopy. Expression of the autophagy-related protein LC3-II was detected by western blotting, and mitochondrial function in each group was evaluated by flow cytometry. Inhibition of Treg cell proliferation was detected by flow cytometry. Results: Mitophagy in the MG group was lower than that in the N group; it was higher in the Rapa group compared to that in the MG group and lowered in the 3-MA group than in the MG group. Expression of the autophagy-related protein LC3-II was lower in the MG group than in the N group, higher in the Rapa group than in the MG group, and lower in the 3-MA group than in the MG group. The mitochondrial membrane potential was lower in the MG group compared to that in the N group; it was higher in the Rapa group than in the MG group and lowered in the 3-MA group than in the MG group. Inhibition of Treg proliferation was lower in the MG group than in the N group; it was higher in the Rapa group than in the MG group and lowered in the 3-MA group than in the MG group. Conclusion: The decreased mitochondrial membrane potential and mitophagy in Tregs in the MG group may be related to a decreased inhibition of Treg proliferation. The mitochondrial membrane potential was increased after adding the autophagy agent Rapa to enhance mitophagy, and the proliferation inhibition function of Tregs was also enhanced. The autophagy agent 3-MA down-regulated mitophagy, which decreased the mitochondrial membrane potential and inhibitory effect of Tregs. These results reveal the possible cellular immune mechanism of Treg dysfunction in MG.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Assessment of esophageal function in patients with myasthenia gravis
    Rainer Linke
    Thomas N. Witt
    Klaus Tatsch
    Journal of Neurology, 2003, 250 : 601 - 606
  • [22] EFFECTS OF ADRENOCORTICOTROPHIC HORMONE ON NEURO-MUSCULAR FUNCTION IN PATIENTS WITH MYASTHENIA GRAVIS
    TORDA, C
    WOLFF, HG
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1949, 71 (03): : 432 - 435
  • [23] Myeloid-derived suppressor cell and regulatory T cell frequencies in canine myasthenia gravis: A pilot study
    Wu, Ying
    Chang, Yu-Mei
    Lawson, Brandon S.
    Galban, Evelyn M.
    Mittelman, Neil S.
    Benedicenti, Leontine
    Petesch, Scott C.
    Carroll, Alicia B.
    Punt, Jennifer A.
    Luo, Jie
    Garden, Oliver A.
    VETERINARY JOURNAL, 2021, 267
  • [24] EFFECTS OF ADRENOCORTICOTROPHIC HORMONE ON NEURO-MUSCULAR FUNCTION IN PATIENTS WITH MYASTHENIA GRAVIS
    TORDA, C
    WOLFF, HG
    JOURNAL OF CLINICAL INVESTIGATION, 1949, 28 (05): : 1228 - 1235
  • [25] EFFECTS OF ADRENOCORTICOTROPHIC HORMONE ON NEURO-MUSCULAR FUNCTION IN PATIENTS WITH MYASTHENIA GRAVIS
    TORDA, C
    WOLFF, HG
    TRANSACTIONS OF THE AMERICAN NEUROLOGICAL ASSOCIATION, 1949, : 135 - 139
  • [26] LYMPHOCYTE-T REGULATORY FACTORS IN MYASTHENIA-GRAVIS (MG)
    SHORE, A
    DOSCH, HM
    LIMATIBUL, S
    GELFAND, EW
    CLINICAL RESEARCH, 1979, 27 (02): : A336 - A336
  • [27] Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells
    Aricha, Revital
    Reuveni, Debby
    Fuchs, Sara
    Souroujon, Miriam C.
    JOURNAL OF AUTOIMMUNITY, 2016, 67 : 57 - 64
  • [28] The role of T regulatory cells in immunopathogenesis of myasthenia gravis: implications for therapeutics
    Alahgholi-Hajibehzad, Mahdi
    Kasapoglu, Pinar
    Jafari, Reza
    Rezaei, Nima
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (07) : 859 - 870
  • [29] Impairment of regulatory T cells in myasthenia gravis: Studies in an experimental model
    Gertel-Lapter, Smadar
    Mizrachi, Keren
    Berrih-Aknin, Sonia
    Fuchs, Sara
    Souroujon, Miriam C.
    AUTOIMMUNITY REVIEWS, 2013, 12 (09) : 894 - 903
  • [30] T cell recognition of the acetylcholine receptor in myasthenia gravis
    Conti-Fine, BM
    Navaneetham, D
    Karachunski, PI
    Raju, R
    Diethelm-Okita, B
    Okita, D
    Howard, J
    Wang, ZY
    MYASTHENIA GRAVIS AND RELATED DISEASES: DISORDERS OF THE NEUROMUSCULAR JUNCTION, 1998, 841 : 283 - 308